32.80
price down icon1.97%   -0.66
after-market アフターアワーズ: 32.80
loading
前日終値:
$33.46
開ける:
$33.28
24時間の取引高:
1.81M
Relative Volume:
1.46
時価総額:
$5.90B
収益:
$520.18M
当期純損益:
$-348.13M
株価収益率:
-17.08
EPS:
-1.92
ネットキャッシュフロー:
$-176.18M
1週間 パフォーマンス:
+4.86%
1か月 パフォーマンス:
-13.55%
6か月 パフォーマンス:
-23.88%
1年 パフォーマンス:
-32.83%
1日の値動き範囲:
Value
$31.68
$33.30
1週間の範囲:
Value
$31.23
$35.11
52週間の値動き範囲:
Value
$29.27
$60.87

Legend Biotech Corp Adr Stock (LEGN) Company Profile

Name
名前
Legend Biotech Corp Adr
Name
セクター
Healthcare (1151)
Name
電話
-
Name
住所
-
Name
職員
2,609
Name
Twitter
@LegendBiotech
Name
次回の収益日
2025-03-11
Name
最新のSEC提出書
Name
LEGN's Discussions on Twitter

LEGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LEGN
Legend Biotech Corp Adr
32.80 5.90B 520.18M -348.13M -176.18M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-08 開始されました Redburn Atlantic Buy
2024-06-17 開始されました Truist Buy
2024-05-24 繰り返されました H.C. Wainwright Buy
2024-05-23 開始されました Deutsche Bank Buy
2024-04-17 アップグレード Scotiabank Sector Perform → Sector Outperform
2024-04-03 開始されました Cantor Fitzgerald Overweight
2024-03-13 開始されました Raymond James Outperform
2023-12-19 開始されました Scotiabank Sector Perform
2023-11-06 開始されました Goldman Buy
2023-05-25 開始されました William Blair Mkt Perform
2023-05-22 開始されました Daiwa Securities Buy
2023-03-29 開始されました H.C. Wainwright Buy
2023-03-24 開始されました RBC Capital Mkts Outperform
2022-12-06 開始されました UBS Buy
2022-11-02 開始されました Evercore ISI Outperform
2022-11-01 開始されました Cowen Outperform
2022-10-31 開始されました Guggenheim Neutral
2022-06-17 開始されました BMO Capital Markets Outperform
2022-03-15 開始されました Barclays Overweight
2022-01-31 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-21 開始されました Piper Sandler Overweight
2021-05-18 開始されました BTIG Research Buy
2020-07-01 開始されました JP Morgan Overweight
2020-07-01 開始されました Jefferies Buy
2020-06-30 開始されました Morgan Stanley Overweight
すべてを表示

Legend Biotech Corp Adr (LEGN) 最新ニュース

pulisher
Apr 16, 2025

Legend Biotech (LEGN) Moves 5.1% Higher: Will This Strength Last? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 11, 2025

Piper Sandler bullish on biotech stocks amid market swings By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 11, 2025

Piper Sandler bullish on biotech stocks amid market swings - Investing.com

Apr 11, 2025
pulisher
Apr 10, 2025

TD Cowen maintains Legend Biotech $62 target on strong Q1 outlook - Investing.com India

Apr 10, 2025
pulisher
Apr 09, 2025

Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains? - Yahoo Finance

Apr 09, 2025
pulisher
Apr 08, 2025

H.C. Wainwright maintains Legend Biotech stock Buy rating, $75 target By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

H.C. Wainwright maintains Legend Biotech stock Buy rating, $75 target - Investing.com

Apr 08, 2025
pulisher
Apr 07, 2025

Legend Biotech stock hits 52-week low at $30.16 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Legend Biotech stock hits 52-week low at $30.16 amid market challenges - Investing.com

Apr 07, 2025
pulisher
Mar 17, 2025

Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

Legend Biotech’s SWOT analysis: carvykti’s strong efficacy drives stock outlook - Investing.com

Mar 17, 2025
pulisher
Mar 13, 2025

Piper Sandler maintains Overweight on Legend Biotech, $78 target By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

RBC Capital maintains Outperform rating on Legend Biotech shares - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

RBC Capital maintains Outperform rating on Legend Biotech shares By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

BMO Capital maintains Legend Biotech at Outperform with $90 target - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

BMO Capital maintains Legend Biotech at Outperform with $90 target By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains Overweight on Legend Biotech, $78 target - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Legend Biotech stock price target raised to $75 at H.C. Wainwright - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Legend Biotech reports Q4 earnings beat, revenue tops estimates By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Legend Biotech reports Q4 earnings beat, revenue tops estimates - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Earnings call transcript: Legend Biotech Q4 2024 sees strong CARVICTI growth By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Earnings call transcript: Legend Biotech Q4 2024 sees strong CARVICTI growth - Investing.com India

Mar 11, 2025
pulisher
Feb 28, 2025

Legend Biotech CorpADR to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 13, 2025

Arcutis Biotherapeutics (ARQT) Surges 15.9%: Is This an Indication of Further Gains? - Yahoo Finance

Feb 13, 2025
pulisher
Feb 11, 2025

Market Momentum: Aptargroup Inc (ATR) Registers a 0.07 Increase, Closing at 143.28 - The Dwinnex

Feb 11, 2025
pulisher
Feb 10, 2025

Legend Biotech Corp ADR (LEGN) rating initates by Redburn Atlantic - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

A Guide To The Risks Of Investing In Worksport Ltd (WKSP) - Knox Daily

Feb 10, 2025
pulisher
Feb 06, 2025

Legend Biotech Corp ADR (LEGN) stock analysis: A comprehensive overview - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

Beyond Meat Inc (BYND)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Deeper Dive: Understanding Legend Biotech Corp ADR (LEGN) Through its Various Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Legend Biotech Corp ADR (LEGN) looking to reclaim success with recent performance - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

CIMG Inc (IMG)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Ratio Analysis: Unpacking XPLR Infrastructure LP (XIFR)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Ratios in Focus: Analyzing Aurora Mobile Ltd ADR (JG)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

Analyze Legend Biotech Corp ADR (NASDAQ: LEGN) Before Investing. - Stocks Register

Feb 03, 2025
pulisher
Jan 28, 2025

Legend Biotech's SWOT analysis: carvykti's efficacy drives stock potential amid competition - Investing.com India

Jan 28, 2025
pulisher
Jan 27, 2025

Barclays lifts Johnson & Johnson stock target to $166 - Investing.com

Jan 27, 2025
pulisher
Jan 24, 2025

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? - Yahoo Finance

Jan 24, 2025
pulisher
Jan 22, 2025

Legend Biotech stock target cut to $91 by Jefferies - Investing.com South Africa

Jan 22, 2025
pulisher
Jan 21, 2025

Legend Biotech keeps stock at Buy rating on strong position - Investing.com India

Jan 21, 2025
pulisher
Jan 20, 2025

When will lagging health care stocks return to healthy growth? - The Globe and Mail

Jan 20, 2025
pulisher
Jan 16, 2025

Legend Biotech's SWOT analysis: carvykti's strong sales fuel stock's potential - Investing.com India

Jan 16, 2025
pulisher
Jan 16, 2025

Legend Biotech's SWOT analysis: carvykti's strong sales fuel stock's potential By Investing.com - Investing.com South Africa

Jan 16, 2025
pulisher
Jan 09, 2025

With BIOSECURE in limbo, should BeiGene or Legend sell itself in 2025? Analysts weigh in - Fierce Pharma

Jan 09, 2025
pulisher
Jan 08, 2025

Legend Biotech's SWOT analysis: carvykti sales boost stock amid competition - Investing.com India

Jan 08, 2025
pulisher
Dec 30, 2024

Legend Biotech's SWOT analysis: carvykti's promise drives stock outlook By Investing.com - Investing.com South Africa

Dec 30, 2024
pulisher
Dec 30, 2024

Legend Biotech's SWOT analysis: carvykti's promise drives stock outlook - Investing.com India

Dec 30, 2024

Legend Biotech Corp Adr (LEGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):